Trends over 5 years in cardiovascular medicine use in Australian veterans with diabetes

Abstract

<h4>Aim</h4>To determine trends over 5 years in cardiovascular medicine use in the Australian veteran population with diabetes.<h4>Methods</h4>An observational study. All veterans dispensed medicines indicative of diabetes between 2000 and 2005 were identified from the Veterans Affairs pharmacy claims dataset. Concurrent dispensings of angiotensin-converting enzyme inhibitor (ACEI), lipid-lowering medicines and antiplatelets were assessed.<h4>Results</h4>ACEI/angiotensin II receptor blocker use has risen from 46% to 67% in the veteran population dispensed medicines indicative of diabetes. Lipid-lowering medicines have increased from 33% to 58% and antiplatelets from 28% to 50%.<h4>Conclusion</h4>The increasing use of cardiovascular medicines in the diabetes population is suggestive of improved treatment practices over time, consistent with guidelines and quality use of medicines initiatives.